Drug intelligence / Profile preview

jiyin jiedu decoction granules

Development stage: Unknown
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

Jiyin Jiedu decoction granules is a Traditional Chinese Medicine (TCM) formulation developed by Guang’anmen Hospital of the China Academy of Chinese Medical Sciences. It is currently being evaluated in clinical trials for the treatment of heart failure with diuretic resistance. The decoction is administered as granules in combination with standard heart failure therapies. Its therapeutic focus is on improving sodium and water excretion and enhancing cardiorenal function in patients who have become unresponsive to conventional diuretics. In the context of TCM theory, the formula is designed to nourish yin (Jiyin) and resolve toxins (Jiedu), addressing the complex pathology of refractory heart failure and edema.

Other names: Jiyin Jiedu FormulaJiyin Jiedu decoction

Beyond the preview

Go deeper on jiyin jiedu decoction granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on jiyin jiedu decoction granules.

Explore the full profile